Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder

Biological Psychiatry

Volumn 44, Issue 1, 1998, Pages 3-14

  Rush, A John ^a   Armitage, Roseanne ^a   Gillin, J Christian ^b,c   Yonkers, Kimberly A ^a   Winokur, Andrew ^d   Moldofsky, Harvey ^e   Vogel, Gerald W ^f   Kaplita, Stephen B ^g   Fleming, Jonathan B ^h   Montplaisir, Jacques ⁱ   Erman, Milton K ^j   Albala, Bruce J ^k   McQuade, Robert D ^l  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BRISTOL MYERS SQUIBB   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^j SCRIPPS CLINIC   (United States)

^k CTA Bio Services Inc   (United States)

^l NONE

more..

Author keywords

Depression; Fluoxetine; Nefazodone; REM sleep; Sleep efficiency; Sleep electroencephalography

Indexed keywords

FLUOXETINE; NEFAZODONE;

ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SOMNOLENCE; VERTIGO; XEROSTOMIA;

ADULT; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CIRCADIAN RHYTHM; COMORBIDITY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP, REM; TRIAZOLES; WAKEFULNESS;

EID: 7144262420     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00092-4     Document Type: Article

References (37)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. 1987;American Psychiatric Press, Washington, DC.
2. Armitage R., Rush A.J., Trivedi M., Cain J., Roffwarg H.P. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology. 10:1994;123-127.
3. Armitage R., Trivedi M., Rush A.J. Fluoxetine and oculomotor activity during sleep in depressed patients. Neuropsychopharmacology. 12:1995;159-165.
4. Armitage R., Yonkers K., Cole D., Rush A.J. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol. 17:1997;161-168.
5. Baldwin D.S., Hawley C.J., Abed R.T., Maragakis B.P., Cox J., Buckingham S.A., et al. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression. J Clin Psychiatry. 57:(suppl 2):1996;46-52.
6. Cohn C.K., Robinson D.S., Roberts D.L., Schwiderski U.E., O'Brien K., Ieni J.R. Responders to antidepressant drug treatment A study comparing nefazodone, imipramine, and placebo in patients with major depression . J Clin Psychiatry. 57:(suppl 2):1996;15-18.
7. Depression Guideline Panel (1993): Clinical Practice Guideline. Number 5. Depression in Primary Care: Volume 2. Treatment of Major Depression. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0551.
8. Dorsey C.M., Lukas S.E., Cunningham S.L. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology. 14:1996;437-442.
9. Eison A.S., Eison M.S., Torrente J.R., Wright R.N., Yocca F.D. Nefazodone Preclinical pharmacology of a new antidepressant . Psychopharmacol Bull. 26:1990;311-315.
10. Feiger A., Kiev A., Shrivastava R.K., Wisselink P.G., Wilcox C.S. Nefazodone versus sertraline in outpatients with major depression Focus on efficacy, tolerability, and effects on sexual function and satisfaction . J Clin Psychiatry. 57:(suppl 2):1996;53-62.
11. Fontaine R., Ontiveros A., Elie R., Kensler T.T., Roberts D.L., Kaplita S., et al. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry. 55:1994;234-241.
12. Gillin J.C., Rapaport M., Erman M.K., Winokur A., Albala B.J. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients A double-blind, 8-week, clinical trial . J Clin Psychiatry. 58:1997;185-192.
13. Guy W (1976): ECDEU Assessment Manual for Psychopharmacology. Washington, DC: U.S. Government Printing Office, Superintendent of Documents. DHEW Publication No. 76-338.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
15. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
16. Hendrickse W.A., Roffwarg H.P., Grannemann B.D., Orsulak P.J., Armitage R., Cain J.W., et al. The effects of fluoxetine on the polysomnogram of depressed outpatients A pilot study . Neuropsychopharmacology. 10:1994;85-91.
17. Keck P.E. Jr, Hudson J.I., Dorsey C.M., Campbell P.I. Effect of fluoxetine on sleep. Biol Psychiatry. 29:1991;618-619.
18. Kerkhofs M., Rielaert C., de Maertelaer V., Linkowski P., Czarka M., Mendlewicz J. Fluoxetine in major depression Efficacy, safety and effects on sleep polygraphic variables . Int Clin Psychopharmacol. 5:1990;253-260.
19. Lian J (1997): Nefazodone treatment of depression requires less use of concomitant anxiolytic and sedative/hypnotic drugs. Paper presented at the annual meeting of the American Psychiatric Association, San Diego, CA. APA New Research Program and Abstracts (NR397), p 175.
20. Mendels J., Reimherr F., Marcus R.N., Roberts D.L., Francis R.J., Anton S.F. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. J Clin Psychiatry. 56:(suppl 6):1995;30-36.
21. Nofzinger E.A., Reynolds C.F. III, Thase M.E., Frank E., Jennings J.R., Fasiczka A.L., et al. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry. 152:1995;274-276.
22. Rechtschaffen A., Kales A. A Manual of Standardized Terminology, Techniques and Scoring for Sleep Stages of Human Subjects. 1968;Neurologic Information Network, NIH Public Health Service, Bethesda, MD.
23. Rickels K., Schweizer E., Clary C., Fox I., Weise C. Nefazodone and imipramine in major depression A placebo-controlled trial . Br J Psychiatry. 164:1994;802-805.
24. Rioux P., Kibleur Y., Frachon O., von Frenckell R., Zariflan E. A double-blind comparison of nefazodone and fluoxetine in depressed patients. Am J Psychiatry. 153:1996;164.
25. Rush A.J., Giles D.E., Schlesser M.A., Fulton C.L., Weissenburger J., Burns C. The Inventory for Depressive Symptomatology (IDS) Preliminary findings . Psychiatry Res. 18:1986;65-87.
26. Rush A.J., Gullion C.M., Basco M.R., Jarret R.B., Trividi M.H. The Inventory of Depressive Symptomatology (IDS) Psychometric properties . Psychol Med. 26:1996;477-486.
27. Sandor P., Shapiro C.M. Sleep patterns in depression and anxiety Theory and pharmacological effects . J Psychosom Res. 38:(suppl 1):1994;125-139.
28. Schenck C.S., Mahowald M.W., Kim S.W., O'Connor K.A., Hurwitz T.D. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep. 15:1992;226-235.
29. Sharpley A.L., Walsh A.E.S., Cowen P.J. Nefazodone - A novel antidepressant - may increase REM sleep. Biol Psychiatry. 31:1992;1070-1073.
30. Sharpley A.L., Williamson D.J., Attenburrow M.E., Pearson G., Sargent P., Cowen P.J. The effects of paroxetine and nefazodone on sleep A placebo controlled trial . Psychopharmacology (Berl). 126:1996;50-54.
31. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID) I History, rationale, and description . Arch Gen Psychiatry. 49:1992;624-629.
32. Taylor D.P., Carter R.B., Eison A.S., Mullins U.L., Smith H.L., Torrente J.R., et al. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry. 55:(suppl 11):1994;3-11.
33. Vogel G.W. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatry. 7:1983;343-349.
34. Vogel G.W., Buffenstein A., Minter K., Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev. 14:1990;49-63.
35. Vogel G., Bohannon M., Hollifield M., Mullis D. Effects of nefazodone on REM sleep. Sleep Res. 24:1995;62.
36. von Bardeleben U., Steiger A., Gerken A., Holsboer F. Effects of fluoxetine upon pharmacoendocrine and sleep EEG parameters in normal controls. Int Clin Psychopharmacol. 4:1989;1-5.
37. Ware J.C., Rose F.V., McBrayer R.H. The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep. 17:1994;544-550.